Diabetes Therapies Market By Segments (Injectables And Oral), By Trends, By Regions, By Key Players And Market Size – Global Forecast To 2023 

Starting Price : $ 4000.00 | Pages : 150 | Published : February 2019 | SKU CODE : o&s074 | Format :

Request Sample

Diabetes Therapies Market Definition

The diabetes therapies market consists of sales of drugs for treating diabetes. Diabetes mellitus, commonly known as diabetes, is a metabolic disorder which impairs the body`s ability to process blood glucose/blood sugar.

Diabetes Therapies Market Size

The global diabetes therapies market reached a value of nearly $50.7 billion in 2018, having grown at a compound annual growth rate (CAGR) of more than 5% since 2014.

Growth in the diabetes therapies market in the historic period resulted from emerging markets growth and ageing population. Factors that negatively affected growth in the historic period were lack of awareness and high investment costs.

Going forward, faster government initiatives, changing lifestyles and developments in drug discovery procedures will drive growth. Factors that could hinder the growth of this market in the future include government regulations, patent expiration of drugs, and trade protectionism.

Diabetes Therapies Market Drivers

The Key drivers of the diabetes therapies market include:

Ageing Population – The increased size of the geriatric population globally contributed to the growth of the diabetes therapies market during the historic period. The incidence of diabetes, particularly type 2 diabetes, rises with increasing age. During 2013-2017, globally the number of people over the age of 65 grew from below 450 million to 601 million - an increase of 33%, according to estimates based on US Population Reference Bureau data. This rise in the geriatric population increased the number of diabetic patients and drove the market during the historic period.

Diabetes Therapies Market Restraints

The key restraints on the diabetes therapies market include:

Patent Expiration of Drugs – Growth in the diabetes therapies market is likely to be affected by expiration of drug patents during the forecast period. Pharmaceutical companies invest heavily in the drug development process. Once a drug candidate (a compound such as a small molecule or an antibody with strong therapeutic potential and favorable medicine-like properties which justifies further development) is developed and approved by the regulatory authorities, companies patent their inventions to protect their intellectual property. During the patency period, the company holding the patent holds exclusivity for manufacturing and distribution. After patency expiry, generic versions of the drugs are manufactured by other companies. The prices of the generics are low in comparison to the original brand of the drug. This negatively impacts the growth of the overall market in value. For instance, the patent for Sanofi-Aventis’ anti-diabetic drug Apidra is set to expire in 2018. The sales of this drug accounted for revenues worth €367 million ($406.1 million) in 2016 and €377 million ($425.3 million) in 2017, for Sanofi-Aventis.

Diabetes Therapies Market Trends

Major trends influencing the diabetes therapies market include:

Innovations - Novel techniques relating to diabetes therapies research and development include gene editing, identification of microbial strain for treatment of diabetes area included. This advancement has created new treatments for treating diabetes.

For example, in December 2016, researchers at Lund University Diabetes Centre in Sweden, worked on CRISPR, a genome modification tool. This resulted into turning off of one of the genes which was responsible for causing diabetes. This effectively decreased beta cell death and increased insulin production in the pancreas.

In March 2018, a research group in China identified a group of Short chain fatty acids (SCFA) producing gut microbiota. It was observed that they can alleviate the symptoms of type 2 diabetes in patients consuming a diet high in fiber. This aids in blood sugar level reduction and body weight in patients under study.

Insulin maker, Novo Nordisk has developed a diabetes pill and it is expected to be launched in 2020. This pill belongs to a blockbuster class of drugs, glucagon like peptide-1 (GLP-1s) that stimulate insulin production. The new drug is expected to generate about $5 billion in annual sales.

Increased Mergers and Acquisitions - Leading metabolic disorders drugs manufacturers are acquiring smaller companies to strengthen their market position. These acquisitions help drug manufacturing companies to develop their portfolio of drugs that can be used for the treatment of diabetes and related metabolic diseases.

For instance, in August 2018, Novo Nordisk acquired Ziylo which is a University of Bristol spin-out company in the UK. Novo Nordisk has full rights to Ziylo’s glucose binding molecule platform to develop glucose responsive insulins. This development is a key strategic area for Novo Nordisk and should result in more effective insulin therapy.

In August 2015, Novo Nordisk acquired Calibrium LLC and MB2 LLC, two US-based biopharmaceutical research companies. Through these acquisitions, Novo Nordisk is expanding its obesity and diabetes product line by integrating Calibrium LLC and MB2 LLC companies.

Opportunities In The Diabetes Therapies Market

Opportunities – The top opportunities in the global diabetes therapies market will arise in the injectables segment which will gain $12.8 billion of global annual sales by 2023. The diabetes therapies market size will gain the most in China. Diabetes therapies market-trend-based strategies include developing new drugs for Type 2 diabetes-associated comorbidities, collaborating with research organizations to discover novel ways to treat diabetes, acquiring smaller companies to strengthen their market position and undertaking R & D into novel techniques such as genome modification tools. Player-adopted strategies in the diabetes therapies industry include expansion through mergers and acquisitions and development of new products.

Diabetes Therapies Market Segmentation

The Diabetes Therapies market is segmented by type and by geography.
By Type- The diabetes therapies market can be segmented by type into
    • a) Injectables
    • b) Oral
Retirement communities had the highest growth rate of nearly 5.3% during the historic period. Major factors for this growth include increasing access to injectables in developing and some underdeveloped countries.
By Geography- The diabetes therapies market is segmented into
    • o North America
      • USA
    • o Western Europe
      • UK
      • Germany
      • France
      • Spain
      • Italy
    • o Asia Pacific
      • China
      • Japan
      • India
      • Australia
    • o Eastern Europe
      • Russia
    • o South America
      • Brazil
    • o Middle East
    • o Africa
North America is the largest market for diabetes therapies, accounting for almost 39% of the global market. It was followed by Asia-Pacific, Western Europe and then the other regions. Going forward, Asia-Pacific and Africa will be the fastest growing regions in this market.

Diabetes Therapies Competitive Landscape

Major Competitors are:
    • • Novo Nordisk A/S
    • • Eli Lilly and Company
    • • Sanofi S.A.
    • • Merck & Company, Inc.
    • • C.H. Boehringer Sohn AG & Ko. KG
Other Competitors Include:
    • • AstraZeneca plc
    • • Johnson & Johnson
    • • Takeda Pharmaceutical Company Ltd.
    • • Sun Pharmaceutical Industries Limited
    • • Biocon Limited

  1. 1.Executive Summary
  2. 2.Table of Contents
  3. 3.List of Figures
  4. 4.List of Tables
  5. 5.Report Structure
  6. 6.Diabetes Therapies Market Characteristics
    • 6.1.Market Definition
    • 6.2.Diabetes Drugs
  7. 7.Diabetes Therapies Market Supply Chain
  8. 8.Diabetes Therapies Market Trends and Strategies
    • 8.1.Development of New Drugs for Diabetes-Associated Comorbidities
    • 8.2.Increase in Partnerships and Collaborations
    • 8.3.Increased Mergers and Acquisitions
    • 8.4.Innovations
  9. 9.Diabetes Therapies Market Size And Growth
    • 9.1.Market Size
    • 9.2.Historic Market Growth, Value ($ Billion)
    • 9.3.Drivers Of The Market 2014-18
    • 9.4.Restraints On The Market 2014-18
    • 9.5.Forecast Market Growth, Value ($ Billion)
    • 9.6.Drivers Of The Market 2018-23
    • 9.7.Restraints On The Market 2018-23
    • 9.8.Global Diabetes Therapies Market, By Segment
    • 9.9.Global Diabetes Therapies Market, Historic and Forecast CAGR, By Segment
  10. 10.Diabetes Therapies Market Regional Analysis
    • 10.1.Global Diabetes Therapies Market, 2018, By Region, Value ($ Billion)
    • 10.2.Global Diabetes Therapies Market, 2014 - 2023, Historic And Forecast, By Region
    • 10.3.Global Diabetes Therapies Market, By Country
    • 10.4.Global Diabetes Therapies Market, Historic and Forecast, By Country
  11. 11.Diabetes Therapies Market Metrics
    • 11.1.Diabetes Therapies Market Size, Percentage Of GDP, Global
    • 11.2.Per Capita Average Diabetes Therapies Expenditure, Global
  12. 12.Asia-Pacific Diabetes Therapies Market
    • 12.1.Asia Pacific Diabetes Therapies Market Overview
      • 12.1.1.Region Information
      • 12.1.2.Market Information
      • 12.1.3.Background Information
      • 12.1.4.Major End User Industries Information
      • 12.1.5.Regulations
      • 12.1.6.Associations
      • 12.1.7.Taxes Levied
      • 12.1.8.Corporate Tax Structure
      • 12.1.9.Collaborations and Partnerships in the Diabetes Therapies Market
      • 12.1.10.Investments and Funding in the Diabetes Therapies Market
      • 12.1.11.Major Companies
    • 12.2.Asia-Pacific Diabetes Therapies Market, 2014 - 2023
    • 12.3.Asia-Pacific Diabetes Therapies Market, By Segment
    • 12.4.Asia-Pacific Diabetes Therapies Market, Historic and Forecast CAGR, By Segment
    • 12.5.Asia-Pacific Diabetes Therapies Market: Country Analysis
    • 12.6.Chinese Diabetes Therapies Market, 2014-2023
    • 12.7.Chinese Market Size, By Segment
    • 12.8.Chinese Diabetes Therapies Market, 2014-2023, Historic and Forecast, By Segment
    • 12.9.Indian Diabetes Therapies Market, 2014-2023
    • 12.10.Indian Market Size, By Segment
    • 12.11.Indian Diabetes Therapies Market, 2014-2023, Historic and Forecast, By Segment
    • 12.12.Japanese Diabetes Therapies Market, 2014-2023
    • 12.13.Japanese Market Size, By Segment
    • 12.14.Japanese Diabetes Therapies Market, 2014-2023, Historic and Forecast, By Segment
    • 12.15.Australia Diabetes Therapies Market, 2014-2023
    • 12.16.Australia Market Size, By Segment
    • 12.17.Australia Diabetes Therapies Market, 2014-2023, Historic and Forecast, By Segment
  13. 13.Western Europe Diabetes Therapies Market
    • 13.1.Western Europe Diabetes Therapies Market Overview
      • 13.1.1.Region Information
      • 13.1.2.Market Information
      • 13.1.3.Background Information
      • 13.1.4.Major End User Industries Information
      • 13.1.5.Regulations
      • 13.1.6.Regulatory Bodies
      • 13.1.7.Associations
      • 13.1.8.Taxes Levied
      • 13.1.9.Corporate Tax Structure
      • 13.1.10.Collaborations and Partnerships in the Diabetes Therapies Market
      • 13.1.11.Investments and Funding in the Diabetes Therapies Market
      • 13.1.12.Major Companies
    • 13.2.Western Europe Diabetes Therapies Market, 2014 - 2023
    • 13.3.Western Europe Diabetes Therapies Market, By Segment
    • 13.4.Western Europe Diabetes Therapies Market, Historic and Forecast CAGR, By Segment
    • 13.5.Western Europe Diabetes Therapies Market: Country Analysis
    • 13.6.UK Diabetes Therapies Market, 2014-2023
    • 13.7.UK Market Size, By Segment
    • 13.8.UK Diabetes Therapies Market, 2014-2023, Historic and Forecast, By Segment
    • 13.9.German Diabetes Therapies Market, 2014-2023
    • 13.10.German Market Size, By Segment
    • 13.11.German Diabetes Therapies Market, 2014-2023, Historic and Forecast, By Segment
    • 13.12.France Diabetes Therapies Market, 2014-2023
    • 13.13.French Market Size, By Segment
    • 13.14.French Diabetes Therapies Market, 2014-2023, Historic and Forecast, By Segment
    • 13.15.Italian Diabetes Therapies Market, 2014-2023
    • 13.16.Italian Market Size, By Segment
    • 13.17.Italian Diabetes Therapies Market, 2014-2023, Historic and Forecast, By Segment
    • 13.18.Spain Diabetes Therapies Market, 2014-2023
    • 13.19.Spain Market Size, By Segment
    • 13.20.Spain Diabetes Therapies Market, 2014-2023, Historic and Forecast, By Segment
  14. 14.Eastern Europe Diabetes Therapies Market
    • 14.1.Eastern Europe Diabetes Therapies Market Overview
      • 14.1.1.Region Information
      • 14.1.2.Market Information
      • 14.1.3.Background Information
      • 14.1.4.Major End User Industries Information
      • 14.1.5.Regulations
      • 14.1.6.Regulatory Bodies
      • 14.1.7.Associations
      • 14.1.8.Taxes Levied
      • 14.1.9.Corporate Tax
      • 14.1.10.Investments and Funding in the Diabetes Therapies Market
      • 14.1.11.Major Companies
    • 14.2.Eastern Europe Diabetes Therapies Market, 2014 - 2023
    • 14.3.Eastern Europe Diabetes Therapies Market, By Segment
    • 14.4.Eastern Europe Diabetes Therapies Market, Historic and Forecast CAGR, By Segment
    • 14.5.Eastern Europe Diabetes Therapies Market: Country Analysis
    • 14.6.Russia Diabetes Therapies Market, 2014-2023
    • 14.7.Russia Market Size, By Segment
    • 14.8.Russia Diabetes Therapies Market, 2014-2023, Historic and Forecast, By Segment
  15. 15.North America Diabetes Therapies Market
    • 15.1.North America Diabetes Therapies Market Overview
      • 15.1.1.Region Information
      • 15.1.2.Market Information
      • 15.1.3.Background Information
      • 15.1.4.Major End User Industries Information
      • 15.1.5.Regulations
      • 15.1.6.Regulatory Bodies
      • 15.1.7.Associations
      • 15.1.8.Taxes Levied
      • 15.1.9.Corporate Tax Structure
      • 15.1.10.Collaborations and Partnerships in the Diabetes Therapies Market
      • 15.1.11.Investments and Funding in the Diabetes Therapies Market
      • 15.1.12.Major Companies
    • 15.2.North American Diabetes Therapies Market, 2014 - 2023
    • 15.3.North American Diabetes Therapies Market, By Segment
    • 15.4.North American Diabetes Therapies Market, Historic and Forecast CAGR, By Segment
    • 15.5.North American Diabetes Therapies Market: Country Analysis
    • 15.6.USA Diabetes Therapies Market, 2014-2023
    • 15.7.USA Market Size, By Segment
    • 15.8.USA Diabetes Therapies Market, 2014-2023, Historic and Forecast, By Segment
  16. 16.South America Diabetes Therapies Market
    • 16.1.South America Diabetes Therapies Market Overview
      • 16.1.1.Region Information
      • 16.1.2.Market Information
      • 16.1.3.Background Information
      • 16.1.4.Major End User Industries Information
      • 16.1.5.Regulations
      • 16.1.6.Regulatory Bodies
      • 16.1.7.Associations
      • 16.1.8.Taxes Levied
      • 16.1.9.Corporate Tax Structure
      • 16.1.10.Investments and Funding in the Diabetes Therapies Market
      • 16.1.11.Major Companies
    • 16.2.South American Diabetes Therapies Market, 2014 - 2023
    • 16.3.South American Diabetes Therapies Market, By Segment
    • 16.4.South American Diabetes Therapies Market, Historic and Forecast CAGR, By Segment
    • 16.5.South American Diabetes Therapies Market: Country Analysis
    • 16.6.Brazil Diabetes Therapies Market, 2014-2023
    • 16.7.Brazil Market Size, By Segment
    • 16.8.Brazil Diabetes Therapies Market, 2014-2023, Historic and Forecast, By Segment
  17. 17.Middle East Diabetes Therapies Market
    • 17.1.Middle East Diabetes Therapies Market Overview
      • 17.1.1.Region Information
      • 17.1.2.Market Information
      • 17.1.3.Background Information
      • 17.1.4.Major End User Industries Information
      • 17.1.5.Regulatory Bodies
      • 17.1.6.Associations
      • 17.1.7.Tax levied
      • 17.1.8.Corporate Tax Structure
      • 17.1.9.Collaborations and Partnerships in the Diabetes Therapies Market
      • 17.1.10.Major Companies
    • 17.2.Middle East Diabetes Therapies Market, 2014 - 2023
    • 17.3.Middle East Diabetes Therapies Market, By Segment
    • 17.4.Middle East Diabetes Therapies Market, Historic and Forecast CAGR, By Segment
  18. 18.Africa Diabetes Therapies Market
    • 18.1.Africa Diabetes Therapies Market Overview
      • 18.1.1.Region Information
      • 18.1.2.Market Information
      • 18.1.3.Background Information
      • 18.1.4.Major End User Industries Information
      • 18.1.5.Regulations
      • 18.1.6.Regulatory Bodies
      • 18.1.7.Associations
      • 18.1.8.Taxes Levied
      • 18.1.9.Corporate Tax Structure
      • 18.1.10.Investments and Funding in the Diabetes Therapies Market
      • 18.1.11.Major Companies
    • 18.2.Africa Diabetes Therapies Market, 2014 - 2023
    • 18.3.Africa Diabetes Therapies Market, By Segment
    • 18.4.Africa Diabetes Therapies Market, Historic and Forecast CAGR, By Segment
  19. 19.Diabetes Therapies Market Competitive Landscape
    • 19.1.1.C.H.Boehringer Sohn AG & Ko.KG
    • 19.1.2.Johnson & Johnson
    • 19.1.3.Takeda Pharmaceutical Company Ltd.
    • 19.1.4.Sun Pharmaceutical Industries Limited
    • 19.1.5.Biocon Limited
  20. 19.2.Company Profiles
  21. 19.3.NOVO NORDISK A/S
    • 19.3.1.Company Overview
    • 19.3.2.Products And Services
    • 19.3.3.Product Overview
    • 19.3.4.Research and Development
    • 19.3.5.Collaborations and Partnerships
    • 19.3.6.New Product Launch
    • 19.3.7.Clinical Development
    • 19.3.8.Business Strategy
    • 19.3.9.Financial Overview
  22. 19.4.ELI LILLY AND COMPANY
    • 19.4.1.Company Overview
    • 19.4.2.Products And Services
    • 19.4.3.Product Overview
    • 19.4.4.Research and Development
    • 19.4.5.Collaborations and Partnerships
    • 19.4.6.New Product Launch
    • 19.4.7.Clinical Development
    • 19.4.8.Business Strategy
    • 19.4.9.Financial Overview
  23. 19.5.SANOFI S.A.
    • 19.5.1.Company Overview
    • 19.5.2.Products And Services
    • 19.5.3.Product Overview
    • 19.5.4.Research and Development
    • 19.5.5.Collaborations and Partnerships
    • 19.5.6.New Product Launch
    • 19.5.7.Clinical Development
    • 19.5.8.Business Strategy
    • 19.5.9.Financial Overview
  24. 19.6.MERCK & COMPANY, INC.
    • 19.6.1.Company Overview
    • 19.6.2.Products And Services
    • 19.6.3.Product Overview
    • 19.6.4.Research and Development
    • 19.6.5.Collaborations and Partnerships
    • 19.6.6.New Product Launch
    • 19.6.7.Clinical Development
    • 19.6.8.Business Strategy
    • 19.6.9.Financial Overview
  25. 19.7.C.H.BOEHRINGER SOHN AG & KO.KG
    • 19.7.1.Overview
    • 19.7.2.Products and Services
    • 19.7.3.Product Overview
    • 19.7.4.Research and Development
    • 19.7.5.Collaborations and Partnerships
    • 19.7.6.New Product Launch
    • 19.7.7.Clinical Development
    • 19.7.8.Business Strategy
    • 19.7.9.Financial Overview
  26. 20.Key Mergers And Acquisitions In The Diabetes Therapies Market
    • 20.1.Takeda Pharmaceutical Acquired Shire
    • 20.2.AstraZeneca Acquired Bristol-Myers Squibb’s Diabetes Business
    • 20.3.PHC Holdings Acquired Bayer’s Diabetes Care Business
    • 20.4.Eli Lilly Acquired Glycostasis
    • 20.5.AstraZeneca Acquired ZS Pharma
    • 20.6.Teva Acquired Allergan’s Generic Business
  27. 21.Global Diabetic Therapies Market Opportunities
    • 21.1.Global Diabetic Therapies Market In 2023- Countries Offering Most New Opportunities
    • 21.2.Global Diabetic Therapies Market In 2023- Segments Offering Most New Opportunities
      • 21.2.1.Injectables
      • 21.2.2.Oral
  28. 22.Global Diabetic Therapies Market Strategies
    • 22.1.1.Competitor Strategies
  29. 23.Appendix
    • 23.1.Market Data Sources
    • 23.2.Research Methodology
      • 23.2.1.Methodology
      • 23.2.2.Data
      • 23.2.3.Market Numbers
      • 23.2.4.Competitor Market Share Data
      • 23.2.5.Analysis
      • 23.2.6.Verification through Expert Interviews
      • 23.2.7.Referencing
  30. 25.Appendix
    • 25.1.Market Data Sources
    • 25.2.Research Methodology
    • 25.3.Currencies
    • 25.4.Research Inquiries
    • 25.5.The Business Research Company
  31. 26.Copyright and Disclaim

List Of Tables

    Table 1: Global Diabetes Therapies Market, Historic Market Size, 2014– 2018, $ Billion
  • Table 2: Global Diabetes Therapies Market, Forecast Market Size, 2018– 2023, $ Billion
  • Table 3: Global Diabetes Therapies Market, by Segment, 2018(%/$ Billions)
  • Table 4: Global Diabetes Therapies Historic and Forecast Market Growth Rate, by Segment, Through 2023
  • Table 5: Global Diabetes Therapies Market, 2018, Split By Region
  • Table 6: Global Diabetes Therapies Market, 2014-2023, Historic And Forecast Growth Rate, Split By Region
  • Table 7: Global Diabetes Therapies Market, by Country, 2018  (Billions)
  • Table 8: Global Diabetes Therapies Historic and Forecast Market Growth Rate, by Country, 2014-2023 (%)
  • Table 9: Global Diabetes Therapies Market Value, Market Size As A Percentage Of Global GDP, 2014 – 2022
  • Table 10: Global Diabetes Therapies Market, Per Capita Average Diabetes Therapies Market Expenditure, 2014-2022, ($)
  • Table 11: Asia-Pacific Diabetes Therapies Market, 2014-2023, ($ Billion)
  • Table 12: Asia-Pacific Diabetes Therapies Market, by Segment, 2018 (Billions)
  • Table 13: Asia-Pacific Diabetes Therapies Market Historic and Forecast Growth Rate, by Segment, 2014-2023 (%)
  • Table 14: Chinese Diabetes Therapies Market, 2014-2023, ($ Billion)
  • Table 15: Chinese Diabetes Therapies Market, by Segment, 2018 (Billions)
  • Table 16: Chinese Diabetes Therapies Market Historic and Forecast Growth Rate, by Segments, 2014-2023 (%)
  • Table 17: Indian Diabetes Therapies Market, 2014-2023, ($ Billion)
  • Table 18: Indian Diabetes Therapies Market, by Segment, 2018 (Billions)
  • Table 19: Indian Diabetes Therapies Market Historic and Forecast Growth Rate, by Segments, 2014-2023 (%)
  • Table 20: Japanese Diabetes Therapies Market, 2014-2023, ($ Billion)
  • Table 21: Japanese Diabetes Therapies Market, by Segment, 2018 (Billions)
  • Table 22: Japanese Diabetes Therapies Market Historic and Forecast Growth Rate, by Segments, 2014-2023 (%)
  • Table 23: Australia Diabetes Therapies Market, 2014-2023, ($ Millions)
  • Table 24: Australia Diabetes Therapies Market, by Segment, 2018 (%/$ Millions)
  • Table 25: Australia Diabetes Therapies Market Historic and Forecast Growth Rate, by Segments, 2014-2023 (%)
  • Table 26: Western Europe Diabetes Therapies Market, 2014-2023, ($ Billions)
  • Table 27: Western Europe Diabetes Therapies Market, by Segment, 2018 (Billions)
  • Table 28: Western Europe Diabetes Therapies Market Historic and Forecast Growth Rate, by Segment, 2014-2023 (%)
  • Table 29: UK Diabetes Therapies Market, 2014-2023, ($ Billions)
  • Table 30: UK Diabetes Therapies Market, by Segment, 2018 (Billions)
  • Table 31: UK Diabetes Therapies Market Historic and Forecast Growth Rate, by Segments, 2014-2023 (%)
  • Table 32: German Diabetes Therapies Market, 2014-2023, ($ Billions)
  • Table 33: German Diabetes Therapies Market, by Segment, 2018 (Billions)
  • Table 34: German Diabetes Therapies Market Historic and Forecast Growth Rate, by Segments, 2014-2023 (%)
  • Table 35: French Diabetes Therapies Market, 2014-2023, ($ Billions)
  • Table 36: French Diabetes Therapies Market, by Segment, 2018 (Billions)
  • Table 37: French Diabetes Therapies Market Historic and Forecast Growth Rate, by Segments, 2014-2023 (%)
  • Table 38: Italian Diabetes Therapies Market, 2014-2023, ($ Billions)
  • Table 39: Italian Diabetes Therapies Market, by Segment, 2018 (Billions)
  • Table 40: Italian Diabetes Therapies Market Historic and Forecast Growth Rate, by Segments, 2014-2023 (%)
  • Table 41: Spain Diabetes Therapies Market, 2014-2023, ($ Billions)
  • Table 42: Spain Diabetes Therapies Market, by Segment, 2018 (Billions)
  • Table 43: Spain Diabetes Therapies Market Historic and Forecast Growth Rate, by Segments, 2014-2023 (%)
  • Table 44: Eastern Europe Diabetes Therapies Market, 2014-2023, ($ Billions)
  • Table 45: Eastern Europe Diabetes Therapies Market, by Segment, 2018 (Billions)
  • Table 46: Eastern Europe Diabetes Therapies Market Historic and Forecast Growth Rate, by Segment, 2014-2023 (%)
  • Table 47: Russia Diabetes Therapies Market, 2014-2023, ($ Millions)
  • Table 48: Russia Diabetes Therapies Market, by Segment, 2018 (%/$ Millions)
  • Table 49: Russia Diabetes Therapies Market Historic and Forecast Growth Rate, by Segments, 2014-2023 (%)
  • Table 50: North American Diabetes Therapies Market, 2014-2023, ($ Billions)
  • Table 51: North American Diabetes Therapies Market, by Segment, 2018 (Billions)
  • Table 52: North American Diabetes Therapies Market Historic and Forecast Growth Rate, by Segment, 2014-2023 (%)
  • Table 53: USA Diabetes Therapies Market, 2014-2023, ($ Billions)
  • Table 54: USA Diabetes Therapies Market, by Segment, 2018 (Billions)
  • Table 55: USA Diabetes Therapies Market Historic and Forecast Growth Rate, by Segments, 2014-2023 (%)
  • Table 56: South American Diabetes Therapies Market, 2014-2023, ($ Billions)
  • Table 57: South American Diabetes Therapies Market, by Segment, 2018 (Billions)
  • Table 58: South American Diabetes Therapies Market Historic and Forecast Growth Rate, by Segment, 2014-2023 (%)
  • Table 59: Brazil Diabetes Therapies Market, 2014-2023, ($ Billions)
  • Table 60: Brazil Diabetes Therapies Market, by Segment, 2018 (Billions)
  • Table 61: Brazil Diabetes Therapies Market Historic and Forecast Growth Rate, by Segments, 2014-2023 (%)
  • Table 62: Middle East Diabetes Therapies Market, 2014-2023, ($ Billions)
  • Table 63: Middle East Diabetes Therapies Market, by Segment, 2018 (Billions)
  • Table 64: Middle East Diabetes Therapies Market Historic and Forecast Growth Rate, by Segment, 2014-2023 (%)
  • Table 65: Africa Diabetes Therapies Market, 2014-2023, ($ Billions)
  • Table 66: Africa Diabetes Therapies Market, by Segment, 2018 (Billions)
  • Table 67: Africa Diabetes Therapies Market Historic and Forecast Growth Rate, by Segment, 2014-2023 (%)
  • Table 68: Global Market Shares for Key Competitors of the Diabetes Therapies Market, 2017 ($ Billions/%)
  • Table 69: Novo Nordisk A/S’s Antidiabetic Drugs Overview
  • Table 70: Novo Nordisk A/S – Financial Performance, $ Billion
  • Table 71: Eli Lilly and Company’s Antidiabetic Drugs Overview
  • Table 72: Amazon – Financial Performance, $ Billion
  • Table 73: Sanofi S.A.’s Antidiabetic Drugs Overview
  • Table 74: Sanofi S.A.  – Financial Performance, $ Billion
  • Table 75: Merck & Company, Inc.’s Antidiabetic Drugs Overview
  • Table 76: Merck & Company, Inc.– Financial Performance, $ Billion
  • Table 77: C. H. Boehringer Sohn AG & Co. KG’s Antidiabetic Drugs Overview
  • Table 78: C. H. Boehringer Sohn AG & Co. KG – Financial Performance, $ Billion
  • Table 79 Diabetic Therapies, Market Size Gain ($ Billion), 2018 – 2023, By Country
  • Table 80: Diabetic Therapies, Market Size Gain ($ Billion), 2018 – 2023, By Segment
  • Table 81: Diabetes Therapies Market Data Sources

List Of Figures

    Figure 1:  Diabetes Therapies Market, Value Chain Analysis
  • Figure 2:  Diabetes Therapies Market, Supply Chain Analysis
  • Figure 3:  Global Diabetes Therapies Market, Historic Market Size, 2014-2018, $ Billion
  • Figure 4:  Global Diabetes Therapies Market, Forecast Market Size, 2018-2023 , $ Billion
  • Figure 5: Global Diabetes Therapies Market Share, by Segment, 2018 (%)
  • Figure 6: Global Diabetes Therapies Historic and Forecast Market Growth Rate, by Segment, 2014-2023
  • Figure 7: Global Diabetes Therapies Market, 2018, Split By Region
  • Figure 8: Global Diabetes Therapies Market, 2014-2023, Historic And Forecast Growth Rate, Split By Region
  • Figure 9: Global Diabetes Therapies Market, by Country, 2018 (%)
  • Figure 10: Global Diabetes Therapies Market Historic and Forecast Growth Rate, by Country, 2014-2023 (%)
  • Figure 11: Asia-Pacific Diabetes Therapies Market, 2014-2023 ($ Billions)
  • Figure 12: Asia-Pacific Diabetes Therapies Market Share, by Segment, 2018 (%)
  • Figure 13: Asia-Pacific Diabetes Therapies Market Historic and Forecast Growth Rate, by Segment, 2014-2023
  • Figure 14: Chinese Diabetes Therapies Market, 2014-2023 ($ Billions)
  • Figure 15: Chinese Diabetes Therapies Market Share, by Segments, 2018 (%)
  • Figure 16: Chinese Diabetes Therapies Market Historic and Forecast Growth Rate, by Segments, 2014-2023 (%)
  • Figure 17: Indian Diabetes Therapies Market, 2014-2023 ($ Billions)
  • Figure 18: Indian Diabetes Therapies Market Share, by Segments, 2018 (%)
  • Figure 19: Indian Diabetes Therapies Market Historic and Forecast Growth Rate, by Segments, 2014-2023 (%)
  • Figure 20: Japanese Diabetes Therapies Market, 2014-2023 ($ Billions)
  • Figure 21: Japanese Diabetes Therapies Market Share, by Segments, 2018 (%)
  • Figure 22: Japanese Diabetes Therapies Market Historic and Forecast Growth Rate, by Segments, 2014-2023 (%)
  • Figure 23: Australia Diabetes Therapies Market, 2014-2023 ($ Millions)
  • Figure 24: Australia Diabetes Therapies Market Share, by Segments, 2018 (%)
  • Figure 25: Australia Diabetes Therapies Market Historic and Forecast Growth Rate, by Segments, 2014-2023 (%)
  • Figure 26: Western Europe Diabetes Therapies Market, 2014-2023 ($ Billions)
  • Figure 27: Western Europe Diabetes Therapies Market Share, by Segment, 2018 (%)
  • Figure 28: Western Europe Diabetes Therapies Market Historic and Forecast Growth Rate, by Segment, 2014-2023
  • Figure 29: UK Diabetes Therapies Market, 2014-2023 ($ Billions)
  • Figure 30: UK Diabetes Therapies Market Share, by Segments, 2018 (%)
  • Figure 31: UK Diabetes Therapies Market Historic and Forecast Growth Rate, by Segments, 2014-2023 (%)
  • Figure 32: German Diabetes Therapies Market, 2014-2023 ($ Billions)
  • Figure 33: German Diabetes Therapies Market Share, by Segments, 2018 (%)
  • Figure 34: German Diabetes Therapies Market Historic and Forecast Growth Rate, by Segments, 2014-2023 (%)
  • Figure 35: French Diabetes Therapies Market, 2014-2023 ($ Billions)
  • Figure 36: French Diabetes Therapies Market Share, by Segments, 2018 (%)
  • Figure 37: French Diabetes Therapies Market Historic and Forecast Growth Rate, by Segments, 2014-2023 (%)
  • Figure 38: Italian Diabetes Therapies Market, 2014-2023 ($ Billions)
  • Figure 39: Italian Diabetes Therapies Market Share, by Segments, 2018 (%)
  • Figure 40: Italian Diabetes Therapies Market Historic and Forecast Growth Rate, by Segments, 2014-2023 (%)
  • Figure 41: Spain Diabetes Therapies Market, 2014-2023 ($ Billions)
  • Figure 42: Spain Diabetes Therapies Market Share, by Segments, 2018 (%)
  • Figure 43: Spain Diabetes Therapies Market Historic and Forecast Growth Rate, by Segments, 2014-2023 (%)
  • Figure 44: Eastern Europe Diabetes Therapies Market, 2014-2023 ($ Billions)
  • Figure 45: Eastern Europe Diabetes Therapies Market Share, by Segment, 2018 (%)
  • Figure 46: Eastern Europe Diabetes Therapies Market Historic and Forecast Growth Rate, by Segment, 2014-2023
  • Figure 47: Russia Diabetes Therapies Market, 2014-2023 ($ Millions)
  • Figure 48: Russia Diabetes Therapies Market Share, by Segments, 2018 (%)
  • Figure 49: Russia Diabetes Therapies Market Historic and Forecast Growth Rate, by Segments, 2014-2023 (%)
  • Figure 50: North American Diabetes Therapies Market, 2014-2023 ($ Billions)
  • Figure 51: North American Diabetes Therapies Market Share, by Segment, 2018 (%)
  • Figure 52: North American Diabetes Therapies Market Historic and Forecast Growth Rate, by Segment, 2014-2023
  • Figure 53: USA Diabetes Therapies Market, 2014-2023 ($ Billions)
  • Figure 54: USA Diabetes Therapies Market Share, by Segments, 2018 (%)
  • Figure 55: USA Diabetes Therapies Market Historic and Forecast Growth Rate, by Segments, 2014-2023 (%)
  • Figure 56: South American Diabetes Therapies Market, 2014-2023 ($ Billions)
  • Figure 57: South American Diabetes Therapies Market Share, by Segment, 2018 (%)
  • Figure 58: South American Diabetes Therapies Market Historic and Forecast Growth Rate, by Segment, 2014-2023
  • Figure 59: Brazil Diabetes Therapies Market, 2014-2023 ($ Billions)
  • Figure 60: Brazil Diabetes Therapies Market Share, by Segments, 2018 (%)
  • Figure 61: Brazil Diabetes Therapies Market Historic and Forecast Growth Rate, by Segments, 2014-2023 (%)
  • Figure 62: Middle East Diabetes Therapies Market, 2014-2023 ($ Billions)
  • Figure 63: Middle East Diabetes Therapies Market Share, by Segment, 2018 (%)
  • Figure 64: Middle East Diabetes Therapies Market Historic and Forecast Growth Rate, by Segment, 2014-2023
  • Figure 65: Africa Diabetes Therapies Market, 2014-2023 ($ Billions)
  • Figure 66: Africa Diabetes Therapies Market Share, by Segment, 2018 (%)
  • Figure 67: Africa Diabetes Therapies Market Historic and Forecast Growth Rate, by Segment, 2014-2023
  • Figure 68: Global Market Shares for Key Competitors of the Diabetes Therapies Market, 2017, (%)
  • Figure 69: Novo Nordisk A/S – Financial Performance, $ Billion
  • Figure 70:  Eli Lilly and Company –  Financial Performance, $ Billion
  • Figure 71: Sanofi S.A.  – Financial Performance, $ Billion
  • Figure 72: Merck & Company, Inc. – Financial Performance, $ Billion
  • Figure 73: C. H. Boehringer Sohn AG & Co. KG – Financial Performance, $ Billion
Research And Development Initiatives Taken In The Anti-Infective Drugs Market
Research Initiatives And Funding And Demand For New Medicines For Drug-Resistant Infections In The Anti-Infective Drugs Industry
Global Biologics Market, Opportunities And Strategies Market | Characteristics, Forecast Size, Trends
Biologics Market By Types (Monoclonal Antibodies, Therapeutic Proteins And Vaccines), By Trends, By Regions and By Key Players - Global Forecast To 2021
View Report
Pharmaceutical Drugs Market By Segments (Musculoskeletal Disorders Drugs, Cardiovascular Drugs, Oncology Drugs, Anti-Infective Drugs, Metabolic Disorder Drugs, Central Nervous System Drugs, Genito-Urinary Drugs, Respiratory Diseases Drugs, Gastrointestinal Drugs, Hematology Drugs, Dermatology Drugs, Ophthalmology Drugs) - Global Forecast To 2022
View Report
Cardiovascular Drugs Global Market Report 2019
View Report
Dermatology Drugs Global Market Report 2019
View Report
Gastrointestinal Drugs Global Market Report 2019
View Report
Hematology Drugs Global Market Report 2019
View Report
Metabolic Disorders Drugs Global Market Report 2019
View Report
Musculoskeletal Disorders Drugs Global Market Report 2019
View Report

Call Us

+1 3156230293

(Americas)

+44 2071930708

(Europe)

+91 8897263534

(Asia & Others)